Cirrhosis: Clinical sciences

4,536views

Cirrhosis: Clinical sciences

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

Start
A 58-year-old man presents to the office to follow up on recent blood testing. The patient has no previously diagnosed medical conditions. The patient has been feeling more fatigued recently but attributes it to working long hours. The patient drinks 6-8 cans of beer on weekday evenings and 10-12 cans on weekend days. Temperature is 37.0 ºC (98.6° F), pulse is 84/min, and blood pressure is 132/74 mmHg. Physical exam shows palmar erythema and spider angiomas. Neurologic examination is normal. There is no distension of the abdomen and no abdominal tenderness to palpation. Lab results are shown below. Ultrasound of the abdomen shows a small, nodular liver and minimal ascites. The patient is referred for upper endoscopy which shows medium varices with no signs of active bleeding. Which of the following medications should be started at this time?  

Laboratory value
Result   
Reference range
Blood count  


Hemoglobin
11.0 g/dL
13.5-17.5 g/dL
Platelets
108,000/mm3   
150,000-400,000/mm3   
Metabolic Panel  


BUN
10 mg/dL
7-18 mg/dL
Creatinine
1.5 mg/dL  
0.6-1.2 mg/dL  
AST
118 U/L  
8-40 U/L  
ALT
55 U/L  
8-40 U/L  
Alkaline phosphatase  
165 U/L  
20-70 U/L  
Gamma-glutamyl transpeptidase  
140 U/L  
5-40 U/L  
Total bilirubin  
2.3 mg/dL  
0.1-1 mg/dL  
Albumin
2.8 g/dL  
3.5-5.5 g/dL  
INR
1.4  
≤1.1  

Transcript

Watch video only

Cirrhosis refers to chronic progressive fibrotic changes of the liver parenchyma that occur in response to chronic injury and inflammation. A variety of conditions can cause this injury, including viral hepatitis, chronic alcohol use, autoimmune disease, and hereditary conditions like hemochromatosis or alpha-1 antitrypsin deficiency, and the ensuing fibrotic changes eventually impair liver function.

Early in the disease process, cirrhotic patients remain relatively asymptomatic and are considered to have compensated cirrhosis, while those who present with symptoms are considered to have decompensated cirrhosis. Complications due to cirrhosis include spontaneous bacterial peritonitis, ascites, variceal bleeding, hepatic encephalopathy, and hepatorenal syndrome, which can be life-threatening, therefore it’s important to quickly identify these patients who may suddenly decompensate.

Now, if you suspect cirrhosis, first perform an ABCDE assessment to determine if your patient is unstable. Keep in mind that cirrhosis is never unstable unless it's decompensated and the patient develops complications. If this is the case, you may need to secure the airway, breathing, and circulation, which might require intubating the patient, and starting mechanical ventilation. Next, obtain IV access and, if your patient is hypotensive, start IV fluids for volume resuscitation. If there are signs of blood loss, they might even need a transfusion of blood products, such as packed red blood cells, platelets, and even fresh frozen plasma. You should also continuously monitor vital signs.

Additionally, if you suspect decompensated cirrhosis complications, it’s important to identify the underlying cause and complication. To do so, start by performing a focused history and physical examination, and depending on the suspected complication, you may want to order labs or ultrasound.

Alright, if your patient presents with abdominal distension and a palpable fluid wave, and ultrasound reveals free fluid in the peritoneal cavity, that’s ascites. On the other hand, if your patient has fever and abdominal pain, and labs reveal a positive ascitic fluid culture with PMN predominance, your patient has spontaneous bacterial peritonitis. If you notice signs of blood loss, such as melena, hematochezia, and hematemesis, with anemia on labs, think of variceal bleeding.

If instead your patient presents with neurologic signs, such as altered mental status and flapping tremor, also known as asterixis, that’s hepatic encephalopathy. Lastly, if your patient has dark urine and oliguria, and their labs show elevated creatinine, but there’s no evidence of an intrinsic kidney disease, you should think of hepatorenal syndrome, keeping in mind that it’s a diagnosis of exclusion. Once you’ve identified your patient’s specific complication, the management includes treatment of the underlying cause and complication, including consulting the appropriate specialists and the surgical team. For definitive treatment, consider liver transplantation.

Now, here’s a clinical pearl to keep in mind! Active variceal bleeding in a cirrhotic patient carries a high mortality rate and can be challenging to manage. Not only is the presence of variceal bleeding associated with advanced disease in the first place, but variceal bleeding, by its very nature, is under increased pressure from portal hypertension. Further, cirrhotic patients typically have coagulopathy and thrombocytopenia, so their ability to clot is impaired, and gaining control of the bleeding is not easy. Hypotension and hemorrhagic shock may ensue, and volume resuscitation is challenging since albumin is already low. So, you should use colloids, albumin, and blood products to achieve hemodynamic stability. Finally, immediately call the endoscopy team to stop the bleeding.

Ok so let’s go back to the ABCDE assessment where your patient is instead stable and cover compensated cirrhosis. First, obtain a focused history and physical examination, as well as labs, including CBC, CMP, PT, PTT, and possibly ammonia level. In compensated cirrhosis, the remaining healthy liver parenchyma is still able to compensate for systemic demands of liver function. As a result, these patients are usually asymptomatic, and they haven’t developed overt complications from cirrhosis; some may present with varices, but they haven’t had any episodes of variceal bleeding.

Now, since these patients are asymptomatic, they may come to clinical attention on routine lab evaluation. Lab findings might include elevated hepatic transaminases AST and ALT, alkaline phosphatase or ALP, bilirubin, clotting studies like PT and PTT, and ammonia levels; as well as decreased albumin and thrombocytopenia. The combination of these signs, symptoms, and lab findings should lead you to suspect compensated cirrhosis. To confirm the diagnosis, obtain an abdominal ultrasound, as well as ultrasound with elastography. Additionally, you can obtain a liver biopsy, which is the gold standard for diagnosis. Abdominal ultrasound will reveal a small nodular liver, as well as the absence of ascites, while ultrasound with elastography may show increased liver stiffness. Lastly, liver biopsy is not always done, but it may help confirm the diagnosis by showing regenerative nodules and fibrotic tissue.

Okay, now that you’ve confirmed the diagnosis of compensated cirrhosis, let's turn our attention to management. First, you’ll want to treat the underlying cause of cirrhosis. For example, if your patient has viral hepatitis, start them on antiviral medications; or if they use alcohol, encourage abstinence and get them specialty treatment for alcohol use disorder. Also be sure to encourage additional lifestyle modifications, like weight loss for those with steatohepatitis, as well as avoiding heavily processed foods, and limiting hepatotoxic and nephrotoxic medications, like NSAIDs.

Offer vaccination for Hepatitis A and B, and screen for hepatocellular carcinoma every 6 months by obtaining an ultrasound with or without measuring blood concentrations of alpha-fetoprotein. You should also screen for esophageal varices at the time of diagnosis and every 2 to 3 years thereafter. In addition, calculate your patient’s MELD-Na score and Child-Pugh scores. Lastly consult the surgical team for transfer to a transplant center as your patient could be a candidate for liver transplant. Transplant is the only definitive treatment for cirrhosis.

Sources

  1. "AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis" Hepatology (2023)
  2. "AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis" Hepatology (2022)
  3. "Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases" Hepatology (2021)
  4. "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation" Am Fam Physician (2006)
  5. "Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis" J Coll Physicians Surg Pak (2010)